
Absorla Tablet (Apremilast)
30mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Apremilast is an ingredient that reduces inflammation and modulates the immune response in autoimmune diseases.
MFDS ingredient code M266637
Apremilast belongs to the phosphodiesterase 4 (PDE4) inhibitor class of drugs. It is primarily used in the treatment of autoimmune diseases and is used to reduce inflammation and modulate excessive immune responses.
Apremilast inhibits the degradation of cAMP, an intracellular signaling molecule, thereby decreasing the production of inflammatory mediators. This results in the alleviation of inflammatory responses and the modulation of excessive activation of immune cells.
Approved uses differ by product. Check each product's information for its actual use.
Unlike conventional immunosuppressants, Apremilast targets specific enzymes to regulate inflammation. This leads to a different side effect profile, and it is characterized by its ability to be taken orally.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
5 total

30mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

10mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

10mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

30mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

30mg
Tablet · Prescription medication
Hanlim Pharmaceutical Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.